Technical Analysis for MRNA - Moderna, Inc.

Grade Last Price % Change Price Change
grade C 22.73 0.58% 0.13
MRNA closed down 2.08 percent on Monday, May 20, 2019, on 62 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
10 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical MRNA trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.58%
180 Bearish Setup Bearish Swing Setup 0.58%
Stochastic Buy Signal Bullish 0.58%
Oversold Stochastic Weakness 0.58%
Fell Below 50 DMA Bearish -1.52%
MACD Bearish Centerline Cross Bearish -1.52%
Hammer Candlestick Bullish -1.52%
Lizard Bullish Bullish Day Trade Setup -1.52%
Lower Bollinger Band Touch Weakness -1.52%
Oversold Stochastic Weakness -1.52%

Older signals for MRNA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:

Profile
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Cancer Life Sciences Biology RNA Messenger RNA
Is MRNA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 17 Moderna Announces Publication of Preclinical Data for Chikungunya Antibody Program
May 16 Moderna Aims To Revolutionize Modern Medicine With A New Class Of Drugs
May 15 Moderna Reveals First Data on Its Personalized Cancer Vaccines
May 10 Uber's First Day On Wall Street
May 10 Moderna up 1% premarket on early-stage data on flu vaccine candidates
May 9 Moderna, Inc. (MRNA) CEO Stéphane Bancel on Q1 2019 Results - Earnings Call Transcript
May 8 In slow year for life science IPOs, this venture firm is making big money
May 8 Moderna, Inc. (MRNA) Q1 2019 Earnings Call Transcript
May 8 Moderna reports Q1 results
May 8 The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split
See more MRNA news...
Indicators
Indicator Value
52 Week High 29.79
52 Week Low 13.03
Average Volume 896,147
200-Day Moving Average 0.0
50-Day Moving Average 23.2414
20-Day Moving Average 24.961
10-Day Moving Average 23.655
Average True Range 1.6287
ADX 18.52
+DI 19.7613
-DI 23.8348
Chandelier Exit (Long, 3 ATRs ) 24.0639
Chandelier Exit (Short, 3 ATRs ) 26.5661
Upper Bollinger Band 28.0995
Lower Bollinger Band 21.8225
Percent B (%b) 0.12
BandWidth 25.14723
MACD Line -0.1935
MACD Signal Line 0.2569
MACD Histogram -0.4504
Fundamentals Value
Market Cap 206.47 Million
Num Shares 9.14 Million
EPS -3.84
Price-to-Earnings (P/E) Ratio -5.89
Price-to-Sales 4.85
Price-to-Book 0.47
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.18
Resistance 3 (R3) 24.33 23.97 23.91
Resistance 2 (R2) 23.97 23.57 23.89 23.82
Resistance 1 (R1) 23.28 23.32 23.10 23.13 23.74
Pivot Point 22.92 22.92 22.83 22.84 22.92
Support 1 (S1) 22.23 22.52 22.05 22.08 21.46
Support 2 (S2) 21.87 22.27 21.79 21.38
Support 3 (S3) 21.18 21.87 21.29
Support 4 (S4) 21.03